ConductScience.org, home

Paper387223

Toxic effects of cis-dichlorodiammineplatinum(II) in man.

Von Hoff DD and 6 others. Cancer Treat Rep, 1979. Cited by 511 papers, by iCite.

Cite this record

ConductScience Library. Toxic effects of cis-dichlorodiammineplatinum(II) in man. Papers, record 387223. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/387223

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1979
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
511
iCite
Relative citation ratio, by iCite
21.1
iCite
Revised in PubMed
2022-03-09
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Von Hoff DDD D
2Schilsky RR
3Reichert CMC M
4Reddick RLR L
5Rozencweig MM
6Young RCR C
7Muggia FMF M

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone MarrowMajor topic
CisplatinMajor topic
Digestive SystemMajor topic
Drug HypersensitivityMajor topic
HearingMajor topic
Anemia
Heart
Humans
Leukopenia
Magnesium
Neoplasms
Nervous System
Thrombocytopenia

Source PubMed

Download CSV of topics

Cited by113

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 511 citations.

PMIDTitleJournalYearIn PapersSource
37936720Alginate-based hydrogel platform embedding silver nanoparticles and cisplatin: characterization of the synergistic effect on a breast cancer cell line.Front Mol Biosci2023https://conductscience.org/library/papers/37936720PubMed
34575266Estimated Glomerular Filtration Rate as a Prognostic Factor in Urothelial Carcinoma of the Upper Urinary Tract: A Systematic Review and Meta-Analysis.J Clin Med2021https://conductscience.org/library/papers/34575266PubMed
30478746The role of p53 status on the synergistic effect of CKD-602 and cisplatin on oral squamous cell carcinoma cell lines.Mol Biol Rep2019https://conductscience.org/library/papers/30478746PubMed
28239674Dietary supplementation of coenzyme Q10 plus multivitamins to hamper the ROS mediated cisplatin ototoxicity in humans: A pilot study.Heliyon2017https://conductscience.org/library/papers/28239674PubMed
28133529Cisplatin cytotoxicity is dependent on mitochondrial respiration in Saccharomyces cerevisiae.Iran J Basic Med Sci2017https://conductscience.org/library/papers/28133529PubMed
27891174Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro.Chin Med2016https://conductscience.org/library/papers/27891174PubMed
27555930Crystal structures of organoplatinum complexes containing alkyl-eugenoxyacetate and p-chloro-aniline.Acta Crystallogr E Crystallogr Commun2016https://conductscience.org/library/papers/27555930PubMed
27386491The implication and potential applications of high-mobility group box 1 protein in breast cancer.Ann Transl Med2016https://conductscience.org/library/papers/27386491PubMed
27350330Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity.Sci Rep2016https://conductscience.org/library/papers/27350330PubMed
27087169Minimal C-terminal modification boosts peptide self-assembling ability for necroptosis of cancer cells.Chem Commun (Camb)2016https://conductscience.org/library/papers/27087169PubMed
26336575Development of a Nanoparticle-Embedded Chitosan Sponge for Topical and Local Administration of Chemotherapeutic Agents.J Nanotechnol Eng Med2014https://conductscience.org/library/papers/26336575PubMed
26245970Glutamate Receptors in the Central Nucleus of the Amygdala Mediate Cisplatin-Induced Malaise and Energy Balance Dysregulation through Direct Hindbrain Projections.J Neurosci2015https://conductscience.org/library/papers/26245970PubMed
25631345Ghrelin partially protects against cisplatin-induced male murine gonadal toxicity in a GHSR-1a-dependent manner.Biol Reprod2015https://conductscience.org/library/papers/25631345PubMed
25400453Mechanism of gastrointestinal abnormal motor activity induced by cisplatin in conscious dogs.World J Gastroenterol2014https://conductscience.org/library/papers/25400453PubMed
25194927Management of pediatric and adult patients with medulloblastoma.Curr Treat Options Oncol2014https://conductscience.org/library/papers/25194927PubMed
24687190Interventions for preventing neuropathy caused by cisplatin and related compounds.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24687190PubMed
24403503Understanding and improving platinum anticancer drugs--phenanthriplatin.Anticancer Res2014https://conductscience.org/library/papers/24403503PubMed
23861604Impact of denosumab on bone mass in cancer patients.Clin Pharmacol2013https://conductscience.org/library/papers/23861604PubMed
23548607Comparison of cochlear cell death caused by cisplatin, alone and in combination with furosemide.Toxicol Pathol2014https://conductscience.org/library/papers/23548607PubMed
22312559Neurotoxicity caused by the treatment with platinum analogues.Chemother Res Pract2011https://conductscience.org/library/papers/22312559PubMed

See all 113 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/387223

GET https://conductscience.org/api/papers/v1/387223/cited_by?page=2